CLARITY News and Research

RSS

The lipid-exchanged, anatomically rigid, imaging/immunostaining compatible, tissue hydrogel (CLARITY) method was initially designed in 2013 by Chung and Deisseroth at the Stanford University School of Medicine. Using this process, post-mortem organs can be labeled for proteins and nucleic acids, enabling analysis of intact samples to create detailed 3D images.

Jonathan Richman to present at FDA public hearing on promoting medical devices using the Internet

Bridge Worldwide announced today that Jonathan Richman, Director of Strategic Planning, will present at the public hearing on "Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools," to be held on November 12 and 13, 2009, from 8 a.m. to 5 p.m., at the National Transportation Safety Board Conference Center in Washington, D.C. Richman is scheduled to speak on Friday, November 13, at 11:40 a.m. and 2:40 p.m. for 10 minutes per time slot. To listen to a free, live webcast of the hearing, go to: www.capitolconnection.net/capcon/fda/111209/FDAlive.htm.

12 Nov 2009

New robotic surgical systems from El Camino Hospital

El Camino Hospital, the hospital of Silicon Valley, expands its minimally invasive surgical program to three da Vinci® Si HD Surgical Systems. Physicians performed more than 500 robotic surgeries over the past year and expect the number to increase in 2010 as more physicians undergo training with the enhanced equipment that allows for more minimally invasive procedures.

11 Nov 2009

Access MediQuip relocates its corporate headquarters to Lake Mary, Florida

Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today that it is relocating its corporate headquarters to Lake Mary, Florida. The move, prompted by the firm's continued rapid growth, includes a major expansion of the Primera Blvd, Lake Mary office space that will open in January 2010 and relocation and expansion of the Houston facilities to the new, LEED® certified, One & Two Oak Park complex in the Westchase District.

9 Nov 2009

Renewal Laboratories to produce functional beverages with anti-oxidants and omega3 fatty acids

Renewal Laboratories announced today that it has developed a patent pending process to produce functional beverages with important anti-oxidants and omega3 fatty acids. Natural, nutritionally important supplements such as Coenzyme Q10, resveratrol, and omega3 fish oil may now be offered in appealing and refreshing drinks.

9 Nov 2009

St. David's Medical Center to use FDA cleared CARTO 3 Navigation System for treating cardiac arrhythmia

On Monday, November 2, 2009, Andrea Natale, M.D., F.A.C.C., F.H.R.S., an electrophysiologist and executive medical director of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, will be the first physician in the United States to perform an ablation procedure to treat a patient with a cardiac arrhythmia, commonly known as an irregular heart rhythm, using the newly FDA-cleared CARTO® 3 Navigation System.

2 Nov 2009

New Aplio MX ultrasound system from Toshiba

Hospitals use ultrasound as a first-line diagnostic exam, requiring them to have cutting-edge ultrasound technology available to quickly and efficiently perform a range of patient exams. To meet these demanding clinical needs, while also considering the financial challenges facing many hospitals today, Toshiba America Medical Systems, Inc. has introduced the AplioTM MX ultrasound system, a compact system that offers premium clinical performance and high-end features at an affordable price point.

2 Nov 2009

GE Healthcare to showcase its sophisticated imaging systems for oncology at the ASTRO meeting

According to the American Cancer Society, more than one million people are diagnosed with cancer each year. In the United States, about 1 out of every 2 men and 1 out of every 3 women will have some type of cancer at some point during their lifetime. The sooner a cancer is detected and treatment begins, the better the patient’s chances for survival.

31 Oct 2009

Current measurement of diabetes care quality is complex and cumbersome, says NCDP

The National Changing Diabetes® Program (NCDP) announced today results of a study that found extraordinary variety in the measurement of clinical processes critical to optimal diabetes management such as blood pressure and glucose levels.

30 Oct 2009

La Jolla Institute dedicates new Elam Discovery Wall and Type 1 Diabetes Center

The La Jolla Institute for Allergy & Immunology, an international leader in immunology research and San Diego's only research institute focused solely on immune-mediated diseases, today will dedicate its new Elam Discovery Wall and Type 1 Diabetes Center, which will focus on research into novel immunological-focused approaches to type 1 diabetes.

30 Oct 2009

Resonant Medical to display the next generation of software for its Clarity System

Resonant Medical, an innovator in 3D soft tissue planning, image-guidance and adaptive radiotherapy products, headquartered in Montreal, Canada, today announced that the Company is exhibiting the next generation of software for its Clarity System at the 51st annual American Society of Radiation Oncology (ASTRO) Annual Meeting taking place November 1-5, 2009 in Chicago.

27 Oct 2009

New data demonstrates CREON Delayed-Release Capsules improve fat absorption in adults with EPI

Solvay Pharmaceuticals, Inc. announced that new data demonstrate that CREON®( )(pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in adults with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP) or pancreatic surgery.

27 Oct 2009

Elekta to demonstrate stereotactic solutions at the 2009 CNS Annual Meeting

At the 2009 Congress of Neurological Surgeons (CNS) Annual Meeting, October 24-28 in New Orleans, Louisiana, Elekta will demonstrate how its line of stereotactic solutions expand treatment capabilities and bring new hope for patients presenting serious conditions.

From Elekta 24 Oct 2009

VisionGraft Sterile Cornea allograft now available at Tissue Banks International

Tissue Banks International (TBI) has announced the availability of the VisionGraft Sterile Cornea, the nation's first sterile cornea allograft. The VisionGraft Sterile Cornea (patent pending) is an irradiated cornea for use in tectonic transplant procedures.

22 Oct 2009

USP offers redesigned pharmaceutical standards format to improve key documentation process

To improve key documentation relied upon by the pharmaceutical industry and others, the U.S. Pharmacopeial (USP) Convention announces the release of the redesigned United States Pharmacopeia-National Formulary (USP-NF).

20 Oct 2009

VideoMD.com chosen as a Top 10 Finalist for The Perfect Pitch 2009

VideoMD.com is pleased to announce that it has been selected as a Top 10 Finalist for The Perfect Pitch 2009, an Entrepreneur and Investor Conference. There were over 1000 submissions for The Perfect Pitch, which were evaluated on clarity, viability, consumer need, growth potential, marketing strategy, team capability, scalability, and competitive advantage.

14 Oct 2009

Courtyard Group commends Auditor General's report on eHealth initiative

Courtyard Group today responded after reviewing details of the Ontario Auditor General's report on the eHealth initiative.

9 Oct 2009

Clarity offers new amplified telephone at no cost for people with hearing loss

Florida Telecommunications Relay, Inc. (FTRI), the non-profit distributor of specialized telecommunications equipment for people with hearing loss and speech disabilities, is offering a new amplified telephone developed by Clarity, a division of Plantronics, at no cost to seniors and others with hearing loss. The Clarity W425 Pro cordless telephone amplifies incoming sounds up to 45 dB.

9 Oct 2009

HCRI commences patient enrollment in dual antiplatelet therapy study

The Harvard Clinical Research Institute (HCRI) announced today that the first patients have been enrolled in the DAPT Study, marking the official initiation of the four-year clinical trial to investigate the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.

3 Oct 2009

$Hip fracture patients more likely to be evaluated for osteoporosis than wrist fracture patients$

Hip fracture patients more likely to be evaluated for osteoporosis than wrist fracture patients

A study published in the October 2009 issue of the Journal of Bone and Joint Surgery suggests a disconnect between the way wrist-fracture patients and those with a spine or hip fracture are managed and evaluated. The study, conducted in 2007 among 97 percent of the women in Korea, reviewed the incidence of fractures around the hip, spine, and wrist in female patients age 50 and older and the prescription frequencies of bone density scans for osteoporosis, along with the use of medications for its treatment.